nach oben

Clinical Oral Investigations

Erschienen in:

01.02.2024 | Research

Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis

verfasst von: Beibei Wu, Tong Zhang, Ning Dai, Ding Luo, Xuejie Wang, Chen Qiao, Jian Liu

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study conducts a systematic bibliometric analysis of tongue cancer publications to identify key topics, hotspots, and research distribution.

Methods

We analyzed tongue cancer publications in the Web of Science core collection database, assessing their quantity and quality. We investigated contributors, including countries, affiliations, journals, authors, and categories, within collaborative networks. Additionally, we synthesized key research findings using various analytical techniques, such as alluvial flow, burstness analysis, cluster analysis, co-occurrence network of associations, and network layer overlay.

Results

From 2000 to 2022, this bibliometric study covers 2205 articles and reviews across 617 journals, involving 72 countries, 2233 institutions, and 11,266 authors. It shows consistent growth, particularly in 2016. Key contributors include China (499 publications), Karolinska Institute (84 publications), Oral Oncology (144 publications), and Tuula Salo (47 publications). Other notable contributors are the USA (16,747 citations), the National Cancer Institute (NCI) (2597 citations), and the Memorial Sloan-Kettering Cancer Center (MSK) (2231 citations). Additionally, there are significant teams led by Tuula Salo and Dalianis. We have identified six primary clusters: #0 apoptosis, #1 depth of invasion, #2 radiotherapy, #3 hpv, #4 tongue cancer, #5 oral cancer. The top ten highly cited documents primarily pertain to epidemiology, prognostic indicators in early-stage oral tongue cancer, and HPV. Additionally, we observed 16 reference clusters, with depth of invasion (#3), young patients (#4), and tumor budding (#6) gaining prominence since 2012, indicating sustained research interests.

Conclusions

This analysis emphasizes the increasing scholarly interest in tongue cancer research. The bibliometric evaluation highlights pivotal recent research themes such as HPV, depth of invasion, tumor budding, and surgical margins.

Clinical relevance

The bibliometric analysis highlights the key topics and studies which have shaped the understanding and management of tongue cancer.

Yosefof E, Hilly O, Stern S, Bachar G, Shpitzer T, Mizrachi A (2020) Squamous cell carcinoma of the oral tongue: distinct epidemiological profile disease. Head Neck 42:2316–2320. https://doi.org/10.1002/hed.26177CrossRefPubMed

Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708CrossRefPubMed

Almangush A, Bello IO, Heikkinen I, Hagström J, Haglund C, Kowalski LP, Nieminen P, Coletta RD, Mäkitie AA, Salo T, Leivo I (2021) Stromal categorization in early oral tongue cancer. Virchows Archiv : Int J Pathol 478:925–932. https://doi.org/10.1007/s00428-020-02930-5CrossRef

Stepan KO, Mazul AL, Larson J, Shah P, Jackson RS, Pipkorn P, Kang SY, Puram SV (2023) Changing epidemiology of oral cavity cancer in the United States. Otolaryngolo-Head Neck Surg 168:761–768. https://doi.org/10.1177/01945998221098011CrossRef

Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620–2623. https://doi.org/10.1002/ijc.22177CrossRefPubMed

Hammarstedt L, Dahlstrand H, Lindquist D, Onelöv L, Ryott M, Luo J, Dalianis T, Ye W, Munck-Wikland E (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988–992. https://doi.org/10.1080/00016480601110170CrossRefPubMed

Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429–1435. https://doi.org/10.1002/cncr.22963CrossRefPubMed

Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol : Off J Am Soc Clin Oncol 26:612–619. https://doi.org/10.1200/jco.2007.14.1713CrossRef

Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366. https://doi.org/10.1002/ijc.24339CrossRefPubMed

10.

Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879–2884. https://doi.org/10.1002/ijc.24994CrossRefPubMed

11.

Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789. https://doi.org/10.1016/s1470-2045(10)70017-6CrossRefPubMedPubMedCentral

12.

Ramqvist T, Dalianis T (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16:1671–1677. https://doi.org/10.3201/eid1611.100452CrossRefPubMedPubMedCentral

13.

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol : Off J Am Soc Clin Oncol 29:4294–4301. https://doi.org/10.1200/jco.2011.36.4596CrossRef

14.

Bigcas JLM, Okuyemi OT (2023) Glossectomy. StatPearls Publishing, Book title

15.

16.

Deva FAL, Kalsotra G, Kalsotra P, Saraf A (2023) Tissue transfer after tongue resection: micro-vascular reconstruction using radial artery free flap versus reconstruction by split thickness skin graft in T2 lesions of tongue carcinoma. Indian J Otolaryngol Head Neck Surg : Off Publ Assoc Otolaryngol India 75:529–539. https://doi.org/10.1007/s12070-022-03380-yCrossRef

17.

Huang CC, Yang TL, Tseng WH, Lee TC, Ko JY (2022) An alternative surgical technique for advanced tongue/tongue base cancer without free flap reconstruction. J Formos Med Assoc Taiwan yi zhi 121:2626–2632. https://doi.org/10.1016/j.jfma.2022.07.007CrossRefPubMed

18.

Brudasca I, Philouze P, Morinière S, Lallemant B, Vergez S, Malard O, Roux PE, Rossello N, Payen C and Céruse P (2023) Transoral Laser microsurgery versus robot-assisted surgery for squamous cell carcinoma of the tongue base (oncological and functional results)-a retrospective GETTEC multicenter study. Journal of clinical medicine 12. https://doi.org/10.3390/jcm12134210

19.

Jozkowiak M, Dyszkiewicz-Konwinska M, Ramlau P, Kranc W, Spaczynska J, Wierzchowski M, Kaczmarek M, Jodynis-Liebert J and Piotrowska-Kempisty H (2021) Individual and combined treatments with methylated resveratrol analogue DMU-214 and gefitinib inhibit tongue cancer cells growth via apoptosis induction and EGFR inhibition. International journal of molecular sciences 22. https://doi.org/10.3390/ijms22126180

20.

Zhan KY, Eskander A, Kang SY, Old MO, Ozer E, Agrawal AA, Carrau RL, Rocco JW, Teknos TN (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 73:152–159. https://doi.org/10.1016/j.oraloncology.2017.08.020CrossRefPubMed

21.

Stern PL, Dalianis T (2021) Oropharyngeal squamous cell carcinoma treatment in the era of immune checkpoint inhibitors. Viruses 13(7):1234. https://doi.org/10.3390/v13071234CrossRefPubMedPubMedCentral

22.

Maula AW, Fuad A, Utarini A (2018) Ten-years trend of dengue research in Indonesia and South-east Asian countries: a bibliometric analysis. Glob Health Action 11:1504398. https://doi.org/10.1080/16549716.2018.1504398CrossRefPubMedPubMedCentral

23.

Baskaran S, Agarwal A, Leisegang K, Pushparaj PN, Panner Selvam MK, Henkel R (2021) An in-depth bibliometric analysis and current perspective on male infertility research. World J Men’s Health 39:302–314. https://doi.org/10.5534/wjmh.180114CrossRef

24.

Rondanelli M, Perna S, Peroni G, Guido D (2016) A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia. J Cosmet Dermatol 15:120–130. https://doi.org/10.1111/jocd.12198CrossRefPubMed

25.

Shen Z, Wu H, Chen Z, Hu J, Pan J, Kong J, Lin T (2022) The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis. Front Oncol 12:843735. https://doi.org/10.3389/fonc.2022.843735CrossRefPubMedPubMedCentral

26.

Ma C, Su H, Li H (2020) Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol 10:627891. https://doi.org/10.3389/fonc.2020.627891CrossRefPubMed

27.

Ma D, Guan B, Song L, Liu Q, Fan Y, Zhao L, Wang T, Zhang Z, Gao Z, Li S, Xu H (2021) A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med 8:734514. https://doi.org/10.3389/fcvm.2021.734514CrossRefPubMedPubMedCentral

28.

Huang L, Xu G, He J, Tian H, Zhou Z, Huang F, Liu Y, Sun M, Liang F (2021) Bibliometric analysis of functional magnetic resonance imaging studies on acupuncture analgesia over the past 20 years. J Pain Res 14:3773–3789. https://doi.org/10.2147/jpr.S340961CrossRefPubMedPubMedCentral

29.

D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529. https://doi.org/10.1056/NEJMoa1506007CrossRefPubMed

30.

Liang YD, Li Y, Zhao J, Wang XY, Zhu HZ, Chen XH (2017) Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res 10:951–964. https://doi.org/10.2147/jpr.S132808CrossRefPubMedPubMedCentral

31.

Baba A, Hashimoto K, Kayama R, Yamauchi H, Ikeda K, Hiroya O (2021) to: Radiological approach for the newly incorporated T staging factor, depth of invasion(DOI), of the oral tongue cancer in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual: assessment of the necessity for elective neck dissection. Jpn J Radiol 39:100CrossRefPubMed

32.

Mao MH, Wang S, Feng ZE, Li JZ, Li H, Qin LZ, Han ZX (2019) Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. Prospect Cohort Stud Oral Oncol 91:79–84. https://doi.org/10.1016/j.oraloncology.2019.01.021CrossRef

33.

Murakami R, Shiraishi S, Yoshida R, Sakata J, Yamana K, Hirosue A, Uchiyama Y, Nakayama H, Yamashita Y (2019) Reliability of MRI-derived depth of invasion of oral tongue cancer. Acad Radiol 26:e180–e186. https://doi.org/10.1016/j.acra.2018.08.021CrossRefPubMed

34.

Melchers LJ, Schuuring E, van Dijk BA, de Bock GH, Witjes MJ, van der Laan BF, van der Wal JE, Roodenburg JL (2012) Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 48:337–342. https://doi.org/10.1016/j.oraloncology.2011.11.007CrossRefPubMed

35.

Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Takita M, Mitsunaga S, Mizoguchi N, Nonaka T, Nakayama Y, Oridate N (2017) Predictive significance of tumor depth and budding for late lymph node metastases in patients with clinical N0 early oral tongue carcinoma. Head Neck Pathol 11:477–486. https://doi.org/10.1007/s12105-017-0814-1CrossRefPubMedPubMedCentral

36.

Marangon Junior H, Rocha VN, Leite CF, de Aguiar MC, Souza PE, Horta MC (2014) Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 43:199–204. https://doi.org/10.1111/jop.12121CrossRef

37.

Xie N, Wang C, Liu X, Li R, Hou J, Chen X, Huang H (2015) Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 44:266–272. https://doi.org/10.1111/jop.12242CrossRef

38.

Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Grénman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36:811–818. https://doi.org/10.1002/hed.23380CrossRefPubMed

39.

Almangush A, Salo T, Hagström J, Leivo I (2014) Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology 65:587–594. https://doi.org/10.1111/his.12471CrossRefPubMed

40.

Hamada M, Ebihara Y, Nagata K, Yano M, Kogashiwa Y, Nakahira M, Sugasawa M, Nagatsuka H, Yasuda M (2020) Podoplanin is an efficient predictor of neck lymph node metastasis in tongue squamous cell carcinoma with low tumor budding grade. Oncol Lett 19:2602–2608. https://doi.org/10.3892/ol.2020.11358CrossRefPubMedPubMedCentral

41.

Yamakawa N, Kirita T, Umeda M, Yanamoto S, Ota Y, Otsuru M, Okura M, Kurita H, Yamada SI, Hasegawa T, Aikawa T, Komori T, Ueda M (2019) Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma. J Surg Oncol 119:370–378. https://doi.org/10.1002/jso.25334CrossRefPubMed

42.

Nair D, Mair M, Singhvi H, Mishra A, Nair S, Agrawal J, Chaturvedi P (2018) Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck 40:1780–1787. https://doi.org/10.1002/hed.25170CrossRefPubMed

43.

Cassidy RJ, Switchenko JM, Jegadeesh N, Sayan M, Ferris MJ, Eaton BR, Higgins KA, Wadsworth JT, Magliocca KR, Saba NF, Beitler JJ (2017) Association of lymphovascular space invasion with locoregional failure and survival in patients with node-negative oral tongue cancers. JAMA Otolaryngol Head Neck Surg 143:382–388CrossRefPubMedPubMedCentral

44.

Alicandri-Ciufelli M, Bonali M, Piccinini A, Marra L, Ghidini A, Cunsolo EM, Maiorana A, Presutti L, Conte PF (2013) Surgical margins in head and neck squamous cell carcinoma: what is “close”? Eur Arch Oto-Rhino 270:2603–9. https://doi.org/10.1007/s00405-012-2317-8CrossRef

45.

Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, Shah JP, Wong RJ, Ghossein RA, Patel SG (2017) A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Neck Surg 143:555–560. https://doi.org/10.1001/jamaoto.2016.4238CrossRef

46.

Singh A, Mishra A, Singhvi H, Sharin F, Bal M, Laskar SG, Prabhash K, Chaturvedi P (2020) Optimum surgical margins in squamous cell carcinoma of the oral tongue: Is the current definition adequate? Oral Oncol 111:104938. https://doi.org/10.1016/j.oraloncology.2020.104938CrossRefPubMed

47.

de Koning KJ, van Es RJJ, Klijn RJ, Breimer GE, Willem Dankbaar J, Braunius WW, van Cann EM, Dieleman FJ, Rijken JA, Tijink BM, de Bree R, Noorlag R (2022) Application and accuracy of ultrasound-guided resections of tongue cancer. Oral Oncol 133:106023. https://doi.org/10.1016/j.oraloncology.2022.106023CrossRefPubMed

48.

de Koning KJ, Koppes SA, de Bree R, Dankbaar JW, Willems SM, van Es RJJ, Noorlag R (2021) Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - comparison with conventional treatment. Oral Oncol 116:105249. https://doi.org/10.1016/j.oraloncology.2021.105249CrossRefPubMed

49.

Tarabichi O, Kanumuri V, Juliano AF, Faquin WC, Cunnane ME, Varvares MA (2018) Intraoperative ultrasound in oral tongue cancer resection: feasibility study and early outcomes. Otolaryngol-Head Neck Surg 158:645–648. https://doi.org/10.1177/0194599817742856CrossRefPubMed

50.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720. https://doi.org/10.1093/jnci/92.9.709CrossRefPubMed

51.

Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89:300–304CrossRefPubMed

52.

Lyon (2007) Monograph on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, France

53.

Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128:2892–2897. https://doi.org/10.1002/ijc.25625CrossRefPubMed

54.

Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, Park KH, Lee H (2017) MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 17:658. https://doi.org/10.1186/s12885-017-3642-5CrossRefPubMedPubMedCentral

55.

Gołąbek K, Hudy D, Świętek A, Gaździcka J, Dąbrowska N, Miśkiewicz-Orczyk K, Zięba N, Misiołek M and Strzelczyk JK (2023) miR-125b-5p, miR-155–3p, and miR-214–5p and target E2F2 gene in oral squamous cell carcinoma. International journal of molecular sciences 24. https://doi.org/10.3390/ijms24076320

56.

Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T (2017) Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget 8:35339–35350. https://doi.org/10.18632/oncotarget.15240CrossRefPubMedPubMedCentral

57.

Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de Wiel B, Kvistborg P, Krijgsman O, van den Braber M, Philips D, Broeks A, van Thienen JV, Mallo HA, Adriaansz S, Ter Meulen S, Pronk LM, Grijpink-Ongering LG, Bruining A, Gittelman RM, Warren S, van Tinteren H, Peeper DS, Haanen J, van Akkooi ACJ, Schumacher TN (2018) Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat Med 24:1655–1661. https://doi.org/10.1038/s41591-018-0198-0CrossRefPubMed

58.

Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch’ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen J, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU (2019) Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. Lancet Oncol 20:948–960. https://doi.org/10.1016/s1470-2045(19)30151-2CrossRefPubMed

59.

Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucianò R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Farè E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS, Chung JH, Salvioni R, Mariani L, Montorsi F (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol : Off J Am Soc Clin Oncol 36:3353–3360. https://doi.org/10.1200/jco.18.01148CrossRef

60.

Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O’Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25:477–486. https://doi.org/10.1038/s41591-018-0337-7CrossRefPubMedPubMedCentral

61.

Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, López-Janeiro A, Porciuncula A, Idoate MA, Inogés S, de Andrea C, López-Diaz de Cerio A, Tejada S, Berraondo P, Villarroel-Espindola F, Choi J, Gúrpide A, Giraldez M, Goicoechea I, Gallego Perez-Larraya J, Sanmamed MF, Perez-Gracia JL, Melero I (2019) Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat Med 25:470–476. https://doi.org/10.1038/s41591-018-0339-5CrossRefPubMed

62.

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet (London, England) 394:1915–1928. https://doi.org/10.1016/s0140-6736(19)32591-7CrossRefPubMed

63.

Zhang H, Yan J, Ren X, Sheng Y, Wang Z, Liang J, Yan Y, Jia Y, Li Z, Hou J (2022) Nimotuzumab combined with neoadjuvant or induction chemotherapy for head and neck squamous cell carcinoma: a retrospective study 24:707–716

64.

Amin N, Maroun CA, El Asmar M, Alkhatib HH, Guller M, Herberg ME, Zhu G, Seiwert TY, Pardoll D, Eisele DW, Fakhry C, Gourin CG, Mandal R (2022) Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review. Head Neck 44:562–571. https://doi.org/10.1002/hed.26935CrossRefPubMed

65.

Shibata H, Saito S, Uppaluri R (2021) Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy. Front Oncol 11:727433. https://doi.org/10.3389/fonc.2021.727433CrossRefPubMedPubMedCentral

66.

Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen YH, Catalano PS, Lako A, Ciantra Z, Weirather JL, Criscitiello S, Luoma A, Chau N, Lorch J, Kass JI, Annino D, Goguen L, Desai A, Ross B, Shah HJ, Jacene HA, Margalit DN, Tishler RB, Wucherpfennig KW, Rodig SJ, Uppaluri R, Haddad RI (2020) Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol 6:1563–1570. https://doi.org/10.1001/jamaoncol.2020.2955CrossRefPubMed

Titel: Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis
verfasst von: Beibei Wu
Tong Zhang
Ning Dai
Ding Luo
Xuejie Wang
Chen Qiao
Jian Liu
Publikationsdatum: 01.02.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 2/2024
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-024-05516-6

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis

Abstract

Objectives

Methods

Results

Conclusions

Clinical relevance

Neu im Fachgebiet Zahnmedizin

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Zahnmedizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2024

Is cone-beam computed tomography (CBCT) an alternative to plain radiography in assessments of dental disease? A study of method agreement in a medically compromised patient population

Antimicrobial effects of clindamycin-loaded platelet-rich fibrin (PRF)

Impact of root canal preparation using two single-file systems on the intra-radicular microbiome of teeth with primary apical periodontitis

Efficacy of personalized 3D-printed osteotomy guide in maximizing fibular utilization and minimizing graft length for reconstruction of large mandibular defect

In silico toxicity and immunological interactions of components of calcium silicate-based and epoxy resin-based endodontic sealers

Autistic individuals have worse oral status than neurotypical controls: a systematic review and meta-analysis of observational studies

Neu im Fachgebiet Zahnmedizin

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Zahnmedizin